Blood DNA methylation and breast cancer risk: a meta-analysis of four prospective cohort studies
Clara Bodelon, Srikant Ambatipudi, Pierre-Antoine Dugue, Annelie Johansson, Joshua N Sampson, Belynda Hicks, Eric Karlins, Amy Hutchinson, Cyrille Cuenin, Veronique Chajes, Melissa C Southey, Isabelle Romieu, Graham G Giles, Dallas English, Silvia Polidoro, Manuela Assumma, Laura Baglietto, Paolo Vineis, Gianluca Severi, Zdenko Herceg Show all
Breast Cancer Research | BMC | Published : 2019
Awarded by National Health and Medical Research Council
This research was partially supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics. The work performed by the Epigenetics Group at IARC was supported by grants from the Institut National du Cancer (INCa, France), the European Commission (EC) Seventh Framework Programme (FP7) Translational Cancer Research (TRANSCAN) Framework, the Fondation ARC pour la Recherche sur le Cancer (France), and la Ligue Nationale (Francaise) Contre le Cancer to ZH. The MCCS methylation work was supported by the National Health and Medical Research Council (grant number 1011618) and the Victorian Breast Cancer Research Consortium. The work performed at Imperial College London was funded by the Breast Cancer Now and supported by the Cancer Research UK Imperial Centre.